Literature DB >> 22760065

Upregulation of alpha and beta integrin subunits in metastatic macrophage-melanoma fusion hybrids.

Ashok K Chakraborty1, Yoko Funasaka, Masamitsu Ichihashi, John M Pawelek.   

Abstract

Fusion of cancer cells with migratory bone-marrow-derived cells such as macrophages can produce cancer cells with increased metastatic potential. To study this, we fused mouse macrophages with weakly metastatic mouse melanoma cells and generated a panel of hybrid clones. About half of these showed increased metastatic potential in mice. These hybrids expressed traits and molecules that were known indicators of tumor progression in melanoma (chemotaxis toward fibronectin, melanogenesis, autophagy, cMet, MCR1, SPARC, cell surface LAMP-1, GnT-V and β1,6-branched oligosaccharides). Here, we investigated integrin subunit expression in selected hybrids. Integrins, especially those that are substrates for the glycosyltransferase GnT-V and carriers of β1,6-branched oligosaccharides, play an important role in cell migration. We report increased expression of the integrin subunits α3, α5, α6, αv, β1, and β3 in metastatic hybrids compared with parental melanoma cells and a weakly metastatic hybrid. Notably, each of these subunits is also a substrate for GnT-V. Integrin subunit expression was further increased by inducers of cyclic AMP. Expression of these integrin subunits is a characteristic of macrophages and also associated with progression in melanoma and other cancers. In summary, our studies of macrophage-melanoma hybrids show that several α and β integrin subunits are upregulated in the metastatic lines. This adds further support for the theory that generation of a metastatic phenotype may be initiated through a single event: fusion of migratory bone marrow-derived cells with cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 22760065     DOI: 10.1097/CMR.0b013e32832fe121

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  8 in total

1.  "Stealth" melanoma cells in histology-negative sentinel lymph nodes.

Authors:  Eijun Itakura; Rong-Rong Huang; Duan-Ren Wen; Alistair J Cochran
Journal:  Am J Surg Pathol       Date:  2011-11       Impact factor: 6.394

2.  The Presence of EpCAM(-)/CD49f(+) Cells in Breast Cancer Is Associated with a Poor Clinical Outcome.

Authors:  Feng Ye; Yan Qiu; Li Li; Libo Yang; Fei Cheng; Hongying Zhang; Bing Wei; Zhang Zhang; Linyong Sun; Hong Bu
Journal:  J Breast Cancer       Date:  2015-09-24       Impact factor: 3.588

3.  High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma.

Authors:  Yu Huang; Yang Kong; Lufei Zhang; Tianyu He; Xiaohu Zhou; Yingcai Yan; Linshi Zhang; Dongkai Zhou; Sinan Lu; Jiarong Zhou; Lin Zhou; Haiyang Xie; Shusen Zheng; Weilin Wang
Journal:  Biomed Res Int       Date:  2018-02-04       Impact factor: 3.411

Review 4.  Leukocyte⁻Cancer Cell Fusion-Genesis of a Deadly Journey.

Authors:  Greggory S Laberge; Eric Duvall; Kay Haedicke; John Pawelek
Journal:  Cells       Date:  2019-02-18       Impact factor: 6.600

5.  Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells.

Authors:  Jeannette Huaman; Michelle Naidoo; Xingxing Zang; Olorunseun O Ogunwobi
Journal:  Cells       Date:  2019-06-20       Impact factor: 6.600

6.  SPARC Controls Melanoma Cell Plasticity through Rac1.

Authors:  Edgardo Salvatierra; Mariano J Alvarez; Claudia C Leishman; Elvia Rivas Baquero; Viviana P Lutzky; H Eduardo Chuluyan; Osvaldo L Podhajcer
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

7.  Identification of novel Kirrel3 gene splice variants in adult human skeletal muscle.

Authors:  Peter Joseph Durcan; Johannes D Conradie; Mari Van deVyver; Kathryn Helen Myburgh
Journal:  BMC Physiol       Date:  2014-12-09

Review 8.  Recent Advances in Studies of Skin Color and Skin Cancer.

Authors:  Greggory S LaBerge; Eric Duvall; Zachary Grasmick; Kay Haedicke; Anjela Galan; Jesse Leverett; Sudhir Baswan; Sunghan Yim; John Pawelek
Journal:  Yale J Biol Med       Date:  2020-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.